| Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden DC Moga, EL Abner, DN Rigsby, L Eckmann, M Huffmyer, RR Murphy, ... Alzheimer's research & therapy 9, 1-10, 2017 | 62 | 2017 |
| INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design … DC Moga, BF Beech, EL Abner, FA Schmitt, RH El Khouli, AI Martinez, ... Trials 20, 1-11, 2019 | 24 | 2019 |
| Primary care clinician and community pharmacist perceptions of deprescribing MJ Huffmyer, JW Keck, NG Harrington, PR Freeman, M Westling, ... Journal of the American Geriatrics Society 69 (6), 1686, 2021 | 17 | 2021 |
| One-year evaluation of a targeted medication therapy management intervention for older adults AI Martinez, EL Abner, GA Jicha, DN Rigsby, LC Eckmann, MJ Huffmyer, ... Journal of managed care & specialty pharmacy 26 (4), 520-528, 2020 | 17 | 2020 |
| Patients’ attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists KM Lukacena, JW Keck, PR Freeman, NG Harrington, MJ Huffmyer, ... Therapeutic Advances in Drug Safety 13, 20420986221116465, 2022 | 13 | 2022 |
| Acceptability of patient-centered, multi-disciplinary medication therapy management recommendations: results from the INCREASE randomized study NI Smith, AI Martinez, M Huffmyer, L Eckmann, R George, EL Abner, ... BMC geriatrics 23 (1), 137, 2023 | 3 | 2023 |
| Rural disparities in emergency department utilization for migraine care C Rhudy, A Schadler, M Huffmyer, L Porter Headache: The Journal of Head and Face Pain 64 (1), 37-47, 2024 | 1 | 2024 |
| Evaluation of a pharmacist-led drive-up anticoagulation clinic during the coronavirus 2019 pandemic E Sherwin, M Schaefer, M Huffmyer, K Naseman, GA Davis, A Schadler, ... Journal of the American Pharmacists Association 63 (1), 151-157. e2, 2023 | 1 | 2023 |
| Intervention for Cognitive Reserve Enhancement in Delaying the Onset of Alzheimer’s Symptomatic Expression (INCREASE) Study: Results from a Randomized Controlled Study of … DC Moga, EL Abner, FA Schmitt, L Eckmann, M Huffmyer, AI Martinez, ... The Journal of Prevention of Alzheimer's Disease 9 (4), 646-654, 2022 | 1 | 2022 |
| Perspectives on the clinical use of anti‐amyloid therapy for the treatment of Alzheimer's disease: Insights from the fields of cancer, rheumatology, and neurology GA Jicha, EL Abner, EP Coskun, MJ Huffmyer, TC Tucker, PT Nelson Alzheimer's & Dementia: Translational Research & Clinical Interventions 10 …, 2024 | | 2024 |
| Multidisciplinary medication therapy management and participant responses to recommendations: Results from the INCREASE trial NI Smith, M Huffmyer, L Eckmann, R George, EL Abner, GA Jicha, ... Alzheimer's & Dementia 18, e066950, 2022 | | 2022 |
| RESULTS FROM A PLATFORM-BASED CLINICAL TRIAL FOR PERSONS DIAGNOSED WITH MILD COGNITIVE IMPAIRMENT A Gibson, C Pope, K Parsons, E Rhodus, M Huffmyer, J Johnston, G Jicha Innovation in Aging 6 (Supplement_1), 451-452, 2022 | | 2022 |
| Does targeted medication therapy management increase cognitive reserve? Results from the INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s … DC Moga, EL Abner, FA Schmitt, L Eckmann, M Huffmyer, AI Martinez, ... Alzheimer's & Dementia 17, e053862, 2021 | | 2021 |
| INCREASE‐DEPTH: MTM and DEPrescribing THerapy recommendations for medication‐related problems among elderly adults in the INCREASE trial NI Smith, M Huffmyer, L Eckmann, AI Martinez, BF Beech, R George, ... Alzheimer's & Dementia 17, e055762, 2021 | | 2021 |
| Cognitive reserve among potentially inappropriate medication users with and without preclinical Alzheimer’s disease: Neuropsychiatry and behavioral neurology/presymptomatic … AI Martinez, GA Jicha, RHE Khouli, FA Schmitt, EL Abner, BF Beech, ... Alzheimer's & Dementia 16, e044842, 2020 | | 2020 |
| Potentially inappropriate medication use associated with lower mobility reserve among individuals with preclinical Alzheimer’s disease: Neuropsychiatry and behavioral neurology … AI Martinez, GA Jicha, K Lee, BF Beech, R George, M Hall, EL Abner, ... Alzheimer's & Dementia 16, e044879, 2020 | | 2020 |
| Medication‐related problems in older adults with and without preclinical Alzheimer’s disease: A baseline description from the INCREASE study: Neuropsychiatry and behavioral … AI Martinez, L Eckmann, M Huffmyer, BF Beech, R George, M Hall, ... Alzheimer's & Dementia 16, e044669, 2020 | | 2020 |
| Cognitive Reserve among Potentially Inappropriate Medication Users with and without Pre-Clinical Alzheimer’s Disease AI Martinez, GA Jicha, RH El Khouli, FA Schmitt, EL Abner, BF Beech, ... 2020 Alzheimer's Association International Conference, 2020 | | 2020 |
| Potentially inappropriate medication users with pre-clinical Alzheimer's disease more susceptible to anticholinergic challenge AI Martinez, BF Beech, EA Abner, GA Jicha, FA Smith, L Eckmann, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 290-291, 2019 | | 2019 |
| P4‐462: INTERVENTION FOR COGNITIVE RESERVE ENHANCEMENT IN DELAYING THE ONSET OF ALZHEIMER'S SYMPTOMATIC EXPRESSION (INCREASE) STUDY‐PROTOCOL AND BASELINE EVALUATION OF PARTICIPANTS DC Moga, EL Abner, FA Schmitt, BF Beech, AI Martinez, L Eckmann, ... Alzheimer's & Dementia 15, P1480-P1481, 2019 | | 2019 |
Daniela C MogaUniversity of Kentucky在 uky.edu 的电子邮件经过验证
